The current stock price of MGRM is 6 USD. In the past month the price increased by 3.81%. In the past year, price increased by 150%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.29 | 219.41B | ||
| ISRG | INTUITIVE SURGICAL INC | 67.95 | 207.41B | ||
| BSX | BOSTON SCIENTIFIC CORP | 33.35 | 145.84B | ||
| SYK | STRYKER CORP | 27.88 | 140.43B | ||
| BDX | BECTON DICKINSON AND CO | 14.23 | 58.56B | ||
| IDXX | IDEXX LABORATORIES INC | 56.49 | 56.88B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.91 | 49.08B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 19.21 | 40.16B | ||
| RMD | RESMED INC | 25.35 | 36.63B | ||
| DXCM | DEXCOM INC | 36.79 | 26.69B | ||
| PODD | INSULET CORP | 64.09 | 20.60B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.63 | 18.64B |
Monogram Technologies, Inc. is a medical technology company, which intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. The company is headquartered in Warsaw Indiana, Indiana and currently employs 27 full-time employees. The company went IPO on 2023-05-18. The firm is developing a product solution architecture to enable patient-optimized orthopedic implants at scale by combining 3D printing, advanced machine vision, AI and robotics. The firm's mBos precision robotic surgical system is designed to autonomously execute optimized paths for high-precision insertion of its FDA-cleared mPress press-fit implants. The firm intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. The company is also exploring other clinical and commercial applications for mBos with mVision navigation. Its mVision technology leverages AI-trained algorithms to track pre-identified objects in real-time.
MONOGRAM TECHNOLOGIES INC
345 East Main Street, Suite 307
Warsaw Indiana INDIANA US
Employees: 27
Phone: 15743733333
Monogram Technologies, Inc. is a medical technology company, which intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. The company is headquartered in Warsaw Indiana, Indiana and currently employs 27 full-time employees. The company went IPO on 2023-05-18. The firm is developing a product solution architecture to enable patient-optimized orthopedic implants at scale by combining 3D printing, advanced machine vision, AI and robotics. The firm's mBos precision robotic surgical system is designed to autonomously execute optimized paths for high-precision insertion of its FDA-cleared mPress press-fit implants. The firm intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. The company is also exploring other clinical and commercial applications for mBos with mVision navigation. Its mVision technology leverages AI-trained algorithms to track pre-identified objects in real-time.
The current stock price of MGRM is 6 USD. The price decreased by -1.8% in the last trading session.
MGRM does not pay a dividend.
MGRM has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
MGRM stock is listed on the Nasdaq exchange.
7 analysts have analysed MGRM and the average price target is 8.57 USD. This implies a price increase of 42.8% is expected in the next year compared to the current price of 6.
MONOGRAM TECHNOLOGIES INC (MGRM) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.55).
ChartMill assigns a technical rating of 10 / 10 to MGRM. When comparing the yearly performance of all stocks, MGRM is one of the better performing stocks in the market, outperforming 97.04% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to MGRM. While MGRM has a great health rating, there are worries on its profitability.
Over the last trailing twelve months MGRM reported a non-GAAP Earnings per Share(EPS) of -0.55. The EPS decreased by -45.02% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -123.05% | ||
| ROE | -214.17% | ||
| Debt/Equity | 0 |
7 analysts have analysed MGRM and the average price target is 8.57 USD. This implies a price increase of 42.8% is expected in the next year compared to the current price of 6.